Patent · US Active

Coagulation factor IX compositions and methods of making and using same

US9062299B2 · kind B2 · utility

10Cited by
23References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2010
Grant dateJun 23, 2015
Priority date
Expiry dateAug 2, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/70
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising factor DC coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.